Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast (DCIS)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00470236 |
Recruitment Status :
Active, not recruiting
First Posted : May 7, 2007
Last Update Posted : March 22, 2023
|
Sponsor:
Trans Tasman Radiation Oncology Group
Collaborators:
Breast International Group
NCIC Clinical Trials Group
Cancer Trials Ireland
Borstkanker Onderzoek Groep
ETOP IBCSG Partners Foundation
Scottish Cancer Trials Breast Group
European Organisation for Research and Treatment of Cancer - EORTC
Information provided by (Responsible Party):
Trans Tasman Radiation Oncology Group
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | June 2024 |
Estimated Study Completion Date : | June 2024 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):